Published in J Bacteriol on June 19, 2009
Penicillin induced persistence in Chlamydia trachomatis: high quality time lapse video analysis of the developmental cycle. PLoS One (2009) 1.31
The Chlamydial Type III Secretion Mechanism: Revealing Cracks in a Tough Nut. Front Microbiol (2010) 1.25
Transformation of a plasmid-free, genital tract isolate of Chlamydia trachomatis with a plasmid vector carrying a deletion in CDS6 revealed that this gene regulates inclusion phenotype. Pathog Dis (2013) 1.04
Fluorescence lifetime imaging unravels C. trachomatis metabolism and its crosstalk with the host cell. PLoS Pathog (2011) 0.86
Biochemical and localization analyses of putative type III secretion translocator proteins CopB and CopB2 of Chlamydia trachomatis reveal significant distinctions. Infect Immun (2011) 0.86
SINC, a type III secreted protein of Chlamydia psittaci, targets the inner nuclear membrane of infected cells and uninfected neighbors. Mol Biol Cell (2015) 0.86
Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci. J Bacteriol (1970) 4.96
Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci U S A (1993) 4.28
Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc Natl Acad Sci U S A (1995) 4.18
Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J (1996) 4.02
A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci U S A (2004) 3.44
Origins and functions of the chlamydial inclusion. Trends Microbiol (1997) 3.28
Effect of penicillin on the multiplication of meningopneumonitis organisms (Chlamydia psittaci). J Bacteriol (1968) 2.98
Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect Immun (1994) 2.58
Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. Mol Microbiol (1999) 2.18
Type III secretion à la Chlamydia. Trends Microbiol (2007) 2.08
Chlamydia trachomatis developmentally regulated protein is homologous to eukaryotic histone H1. Proc Natl Acad Sci U S A (1991) 2.05
Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development. Mol Microbiol (2003) 2.03
Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation. Proc Natl Acad Sci U S A (2003) 1.95
Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol Microbiol (2006) 1.84
Type III secretion genes identify a putative virulence locus of Chlamydia. Mol Microbiol (1997) 1.83
Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteins. Infect Immun (1997) 1.81
Low-nutrient induction of abnormal chlamydial development: a novel component of chlamydial pathogenesis? FEMS Microbiol Lett (1993) 1.56
Reactivation of persistent Chlamydia trachomatis infection in cell culture. Infect Immun (1995) 1.54
Isolation and electron microscopic observations of intracytoplasmic inclusions containing Chlamydia psittaci. J Bacteriol (1981) 1.48
Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells. Infect Immun (2000) 1.34
Analysis of putative Chlamydia trachomatis chaperones Scc2 and Scc3 and their use in the identification of type III secretion substrates. J Bacteriol (2005) 1.33
Type III secretion, contact-dependent model for the intracellular development of chlamydia. Bull Math Biol (2006) 1.30
Electron microscopic observations of surface projections on Chlamydia psittaci reticulate bodies. J Bacteriol (1982) 1.29
Low iron availability modulates the course of Chlamydia pneumoniae infection. Cell Microbiol (2001) 1.28
Phage infection of the obligate intracellular bacterium, Chlamydia psittaci strain guinea pig inclusion conjunctivitis. Microbes Infect (2000) 1.20
CADD, a Chlamydia protein that interacts with death receptors. J Biol Chem (2002) 1.20
Human GCIP interacts with CT847, a novel Chlamydia trachomatis type III secretion substrate, and is degraded in a tissue-culture infection model. Cell Microbiol (2007) 1.11
Temporal expression of type III secretion genes of Chlamydia pneumoniae. Infect Immun (2003) 1.10
Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells. Infect Immun (2002) 1.10
Chlamydia parasitism: ultrastructural characterization of the interaction between the chlamydial cell envelope and the host cell. J Bacteriol (1988) 1.08
Silencing or permanent activation: host-cell responses in models of persistent Chlamydia pneumoniae infection. Cell Microbiol (2005) 1.03
Spatial constraints within the chlamydial host cell inclusion predict interrupted development and persistence. BMC Microbiol (2008) 1.00
Altered mitochondrial structure and motion dynamics in living cells with energy metabolism defects revealed by real time microscope imaging. Microsc Microanal (2004) 0.93
A comparative study of cytoplasmic granules imaged by the real-time microscope, Nile Red and Filipin in fibroblasts from patients with lipid storage diseases. J Inherit Metab Dis (2005) 0.80
Chlamydial persistence: beyond the biphasic paradigm. Infect Immun (2004) 2.78
Type III secretion à la Chlamydia. Trends Microbiol (2007) 2.08
Unity in variety--the pan-genome of the Chlamydiae. Mol Biol Evol (2011) 1.47
Comparison of antigen detection and quantitative PCR in the detection of chlamydial infection in koalas (Phascolarctos cinereus). Vet J (2012) 1.39
Differential expression of three Chlamydia trachomatis hsp60-encoding genes in active vs. persistent infections. Microb Pathog (2004) 1.27
Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease. J Alzheimers Dis (2008) 1.21
Recent advances in understanding the biology, epidemiology and control of chlamydial infections in koalas. Vet Microbiol (2013) 1.21
Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection. Microbes Infect (2002) 1.19
Divergence without difference: phylogenetics and taxonomy of Chlamydia resolved. FEMS Immunol Med Microbiol (2009) 1.19
Chlamydia trachomatis-infected patients display variable antibody profiles against the nine-member polymorphic membrane protein family. Infect Immun (2009) 1.18
Immunopathogenesis of chlamydia trachomatis infections in women. Fertil Steril (2003) 1.15
Molecular evidence to support the expansion of the hostrange of Chlamydophila pneumoniae to include reptiles as well as humans, horses, koalas and amphibians. Syst Appl Microbiol (2002) 1.14
Preliminary phylogenetic identification of virulent Chlamydophila pecorum strains. Infect Genet Evol (2008) 1.14
Ureaplasma parvum and Ureaplasma urealyticum are detected in semen after washing before assisted reproductive technology procedures. Fertil Steril (2003) 1.13
Modeling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection. J Infect Dis (2009) 1.11
Variable expression of surface-exposed polymorphic membrane proteins in in vitro-grown Chlamydia trachomatis. Cell Microbiol (2009) 1.11
Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae. Nanomedicine (2013) 1.09
Chlamydia trachomatis responds to heat shock, penicillin induced persistence, and IFN-gamma persistence by altering levels of the extracytoplasmic stress response protease HtrA. BMC Microbiol (2008) 1.07
Persistent Chlamydiae and chronic arthritis. Arthritis Res (2001) 1.05
Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain. FEMS Immunol Med Microbiol (2006) 1.03
Chlamydia pneumoniae: modern insights into an ancient pathogen. Trends Microbiol (2012) 1.03
Protective immunity to chlamydial genital infection: evidence from animal studies. J Infect Dis (2010) 1.03
Cytokine and chemokine mRNA produced in synovial tissue chronically infected with Chlamydia trachomatis and C. pneumoniae. J Rheumatol (2002) 1.02
Spatial constraints within the chlamydial host cell inclusion predict interrupted development and persistence. BMC Microbiol (2008) 1.00
Wide range of Chlamydiales types detected in native Australian mammals. Vet Microbiol (2003) 1.00
The role of the multiple banded antigen of Ureaplasma parvum in intra-amniotic infection: major virulence factor or decoy? PLoS One (2012) 0.99
Dendrimer-enabled modulation of gene expression in Chlamydia trachomatis. Mol Pharm (2012) 0.99
Altered developmental expression of polymorphic membrane proteins in penicillin-stressed Chlamydia trachomatis. Cell Microbiol (2011) 0.99
Chlamydial infection of immune cells: altered function and implications for disease. Crit Rev Immunol (2009) 0.97
Simultaneous transcriptional profiling of bacteria and their host cells. PLoS One (2013) 0.96
Chlamydophila pneumoniae HflX belongs to an uncharacterized family of conserved GTPases and associates with the Escherichia coli 50S large ribosomal subunit. Microbiology (2008) 0.96
Protein expression profiles of Chlamydia pneumoniae in models of persistence versus those of heat shock stress response. Infect Immun (2006) 0.96
Genotyping of urogenital Chlamydia trachomatis in Regional New South Wales, Australia. Sex Transm Dis (2008) 0.96
Novel molecular markers of Chlamydia pecorum genetic diversity in the koala (Phascolarctos cinereus). BMC Microbiol (2011) 0.96
Chlamydia pneumoniae is genetically diverse in animals and appears to have crossed the host barrier to humans on (at least) two occasions. PLoS Pathog (2010) 0.96
The temperature activated HtrA protease from pathogen Chlamydia trachomatis acts as both a chaperone and protease at 37 degrees C. FEBS Lett (2007) 0.95
A multi-subunit chlamydial vaccine induces antibody and cell-mediated immunity in immunized koalas (Phascolarctos cinereus): comparison of three different adjuvants. Am J Reprod Immunol (2010) 0.94
Chlamydia trachomatis serovars among strains isolated from members of rural indigenous communities and urban populations in Australia. J Clin Microbiol (2007) 0.94
Molecular evidence for novel chlamydial infections in the koala (Phascolarctos cinereus). Syst Appl Microbiol (2003) 0.93
Infectious agents and multiple sclerosis--are Chlamydia pneumoniae and human herpes virus 6 involved? J Neuroimmunol (2003) 0.93
Molecular biology of infectious agents in chronic arthritis. Rheum Dis Clin North Am (2009) 0.93
Vaccination of healthy and diseased koalas (Phascolarctos cinereus) with a Chlamydia pecorum multi-subunit vaccine: evaluation of immunity and pathology. Vaccine (2012) 0.93
Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest Ophthalmol Vis Sci (2004) 0.92
Differential expression of genes encoding membrane proteins between acute and continuous Chlamydia pneumoniae infections. Microb Pathog (2003) 0.92
Comparative genomics of koala, cattle and sheep strains of Chlamydia pecorum. BMC Genomics (2014) 0.91
Dendrimer-enabled transformation of Chlamydia trachomatis. Microb Pathog (2013) 0.91
Ocular chlamydiales infections of western barred bandicoots (Perameles bougainville) in Western Australia. J Zoo Wildl Med (2005) 0.91
Genetic diversity of Chlamydia pecorum strains in wild koala locations across Australia and the implications for a recombinant C. pecorum major outer membrane protein based vaccine. Vet Microbiol (2013) 0.91
Comparison of koala LPCoLN and human strains of Chlamydia pneumoniae highlights extended genetic diversity in the species. BMC Genomics (2010) 0.91
The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype. Microb Pathog (2005) 0.91
High resolution typing of Chlamydophila psittaci by multilocus VNTR analysis (MLVA). Infect Genet Evol (2007) 0.90
Identification of a serine protease inhibitor which causes inclusion vacuole reduction and is lethal to Chlamydia trachomatis. Mol Microbiol (2013) 0.90
Patients with Chlamydia-associated arthritis have ocular (trachoma), not genital, serovars of C. trachomatis in synovial tissue. Microb Pathog (2009) 0.89
Differential expression of chlamydial signal transduction genes in normal and interferon gamma-induced persistent Chlamydophila pneumoniae infections. Microbes Infect (2005) 0.89
Tissue MicroArray (TMA) analysis of normal and persistent Chlamydophila pneumoniae infection. BMC Infect Dis (2006) 0.89
Multilocus sequence analysis provides insights into molecular epidemiology of Chlamydia pecorum infections in Australian sheep, cattle, and koalas. J Clin Microbiol (2013) 0.89
Ocular pathologic response elicited by Chlamydia organisms and the predictive value of quantitative modeling. J Infect Dis (2009) 0.88
Effects of inoculating dose on the kinetics of Chlamydia muridarum genital infection in female mice. Immunol Cell Biol (2009) 0.88
Poly-immunoglobulin receptor-mediated transport of IgA into the male genital tract is important for clearance of Chlamydia muridarum infection. Am J Reprod Immunol (2008) 0.88
Isolation and antimicrobial susceptibilities of Chlamydial isolates from Western barred bandicoots. J Clin Microbiol (2006) 0.88
Molecular characterization of Chlamydophila pneumoniae isolates from Western barred bandicoots. J Med Microbiol (2007) 0.87
CTA1-DD is an effective adjuvant for targeting anti-chlamydial immunity to the murine genital mucosa. J Reprod Immunol (2009) 0.87
Antigenic specificity of a monovalent versus polyvalent MOMP based Chlamydia pecorum vaccine in koalas (Phascolarctos cinereus). Vaccine (2013) 0.85
Multiple genotypes of Chlamydia pneumoniae identified in human carotid plaque. Microbiology (2005) 0.85
A cohort study of Chlamydia trachomatis treatment failure in women: a study protocol. BMC Infect Dis (2013) 0.85
Identification of Chlamydia pneumoniae proteins in the transition from reticulate to elementary body formation. Mol Cell Proteomics (2006) 0.85
A transcriptome resource for the koala (Phascolarctos cinereus): insights into koala retrovirus transcription and sequence diversity. BMC Genomics (2014) 0.85
Identification and characterisation of coding tandem repeat variants in incA gene of Chlamydophila pecorum. Vet Res (2008) 0.84
Genomic plasticity of the rrn-nqrF intergenic segment in the Chlamydiaceae. J Bacteriol (2006) 0.84
Preliminary characterisation of tumor necrosis factor alpha and interleukin-10 responses to Chlamydia pecorum infection in the koala (Phascolarctos cinereus). PLoS One (2013) 0.84
Chlamydophila (Chlamydia) pneumoniae infection of human astrocytes and microglia in culture displays an active, rather than a persistent, phenotype. Am J Med Sci (2006) 0.84
Anti-Müllerian hormone as a predictor of pregnancy following IVF. Reprod Biomed Online (2012) 0.84
Autoimmune Th2-mediated dacryoadenitis in MRL/MpJ mice becomes Th1-mediated in IL-4 deficient MRL/MpJ mice. Invest Ophthalmol Vis Sci (2007) 0.84
Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice. Invest Ophthalmol Vis Sci (2004) 0.84
HtrA, RseP, and Tsp proteins do not elicit a pathology-related serum IgG response during sexually transmitted infection with Chlamydia trachomatis. J Reprod Immunol (2010) 0.84
Unique residues involved in activation of the multitasking protease/chaperone HtrA from Chlamydia trachomatis. PLoS One (2011) 0.83
In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB. Vaccine (2008) 0.83
Reactive arthritis and internal derangement of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 0.83
Fierce competition between Toxoplasma and Chlamydia for host cell structures in dually infected cells. Eukaryot Cell (2012) 0.83
Human herpesvirus 6 and Chlamydia pneumoniae as etiologic agents in multiple sclerosis - a critical review. Microbes Infect (2002) 0.83
Use of quantitative real-time PCR to monitor the shedding and treatment of chlamydiae in the koala (Phascolarctos cinereus). Vet Microbiol (2006) 0.83
Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain. Int J Med Microbiol (2008) 0.83
Pregnancy prognosis in women with anti-Müllerian hormone below the tenth percentile. Gynecol Endocrinol (2013) 0.83
The role of Chlamydia trachomatis polymorphic membrane proteins in inflammation and sequelae among women with pelvic inflammatory disease. Infect Dis Obstet Gynecol (2011) 0.82
Investigation of the koala (Phascolarctos cinereus) hindgut microbiome via 16S pyrosequencing. Vet Microbiol (2013) 0.82
Molecular mimicry and horror autotoxicus: do chlamydial infections elicit autoimmunity? Expert Rev Mol Med (2006) 0.82
the active site residue V266 of Chlamydial HtrA is critical for substrate binding during both in vitro and in vivo conditions. J Mol Microbiol Biotechnol (2012) 0.82
Molecular characterisation and expression analysis of interferon gamma in response to natural Chlamydia infection in the koala, Phascolarctos cinereus. Gene (2013) 0.82
Genus-optimized strategy for the identification of chlamydial type III secretion substrates. Pathog Dis (2013) 0.82
In vitro characterisation of koala Chlamydia pneumoniae: morphology, inclusion development and doubling time. Vet Microbiol (2008) 0.82
Evaluation of intra- and extra-epithelial secretory IgA in chlamydial infections. Immunology (2014) 0.82
Partial protection against chlamydial reproductive tract infection by a recombinant major outer membrane protein/CpG/cholera toxin intranasal vaccine in the guinea pig Chlamydia caviae model. J Reprod Immunol (2011) 0.81
Distribution of Chlamydia pneumoniae DNA in atherosclerotic carotid arteries: significance for sampling procedures. J Clin Microbiol (2003) 0.81
Interaction of microbiology and pathology in women undergoing investigations for infertility. Infect Dis Obstet Gynecol (2005) 0.81
Chlamydia muridarum major outer membrane protein-specific antibodies inhibit in vitro infection but enhance pathology in vivo. Am J Reprod Immunol (2011) 0.81
Apoptosis is induced in Chlamydia trachomatis-infected HEp-2 cells by the addition of a combination innate immune activation compounds and the inhibitor wedelolactone. Am J Reprod Immunol (2010) 0.81